{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T21:28:59Z","timestamp":1779917339525,"version":"3.53.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T00:00:00Z","timestamp":1681257600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T00:00:00Z","timestamp":1681257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Movement disorders (MD) have been linked to degeneration of the substantia nigra (SN) in Parkinson\u2019s disease and include bradykinesia, rigidity, and tremor. They are also present in frontotemporal dementia (FTD), where MD have been linked to frontotemporal lobar degeneration with tau pathology (FTLD-tau). Although MD can also occur in FTLD with TDP-43 pathology (FTLD-TDP), the local pathology in the SN of FTLD-TDP patients with MD is currently unexplored. The aims of this study are to characterize the frequency and the nature of MD in a cohort of FTLD-TDP brain donors and to investigate the relationship between the presence of MD, the nigral neuronal loss, and the TDP-43 burden in the SN. From our cohort of FTLD-TDP patients (n\u2009=\u200953), we included 13 donors who presented with MD (FTLD-MD+), and nine age-sex matched donors without MD (FTLD-MD-) for whom the SN was available. In these donors, the TDP-43 burden and the neuronal density in the SN were assessed with ImageJ and Qupath software. The results were compared between the two groups using T-test. We found that the TDP-43 burden in the SN was higher in FTLD-MD+ (mean 3,43%, SD\u2009\u00b1\u20092,7) compared to FTLD-MD- (mean 1,21%, SD\u2009\u00b1\u20090,67) (p\u2009=\u20090,04), while no significant difference in nigral neuronal density was found between the groups (p\u2009=\u20090,09). 17% of FTLD-TDP patients developed MD, which present as symmetric akinetic-rigid parkinsonism or CBS. Given the absence of a significant nigral neuronal cell loss, TDP-43 induced neuronal dysfunction could be sufficient to cause MD.<\/jats:p>","DOI":"10.1186\/s40478-023-01560-7","type":"journal-article","created":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T11:03:03Z","timestamp":1681297383000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Movement disorders are linked to TDP-43 burden in the substantia nigra of FTLD-TDP brain donors"],"prefix":"10.1186","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8170-8948","authenticated-orcid":false,"given":"Luigi","family":"Fiondella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Gami-Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian A.","family":"Blok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemieke J. M.","family":"Rozemuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen J. M.","family":"Hoozemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The Netherlands Brain Bank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolande A. L.","family":"Pijnenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Scarioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke A.","family":"Dijkstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,12]]},"reference":[{"key":"1560_CR1","unstructured":"Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J et al (2011 Sep) Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 134(9):2456\u20132477"},{"key":"1560_CR2","doi-asserted-by":"crossref","unstructured":"Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF et al Classification of primary progressive aphasia and its variants.Neurology. 2011 Mar15;76(11):1006\u201314","DOI":"10.1212\/WNL.0b013e31821103e6"},{"key":"1560_CR3","doi-asserted-by":"crossref","unstructured":"Forman MS, Farmer J, Johnson JK, Clark CM, Arnold SE, Coslett HB et al (2006 Jun) Frontotemporal dementia: clinicopathological correlations. Ann Neurol 59(6):952\u2013962","DOI":"10.1002\/ana.20873"},{"key":"1560_CR4","doi-asserted-by":"crossref","unstructured":"Espay AJ, Litvan I (2011 Nov) Parkinsonism and frontotemporal dementia: the clinical overlap. J Mol Neurosci MN 45(3):343\u2013349","DOI":"10.1007\/s12031-011-9632-1"},{"key":"1560_CR5","doi-asserted-by":"crossref","unstructured":"de Pablo-Fern\u00e1ndez E, Gonz\u00e1lez-Herrero B, Cerd\u00e1n Santacruz D, Rossor MN, Schott JM, Lashley T et al (2021 Mar) A clinicopathologic study of Movement Disorders in Frontotemporal Lobar Degeneration. Mov Disord Off J Mov Disord Soc 36(3):632\u2013641","DOI":"10.1002\/mds.28356"},{"key":"1560_CR6","doi-asserted-by":"crossref","unstructured":"Baborie A, Griffiths TD, Jaros E, McKeith IG, Burn DJ, Richardson A et al (2011 Mar) Pathological correlates of frontotemporal lobar degeneration in the elderly. Acta Neuropathol (Berl) 121(3):365\u2013371","DOI":"10.1007\/s00401-010-0765-z"},{"key":"1560_CR7","doi-asserted-by":"crossref","unstructured":"Scarioni M, Gami-Patel P, Timar Y, Seelaar H, van Swieten JC, Rozemuller AJM et al (2020 Jun) Frontotemporal Dementia: Correlations between Psychiatric symptoms and Pathology. Ann Neurol 87(6):950\u2013961","DOI":"10.1002\/ana.25739"},{"key":"1560_CR8","doi-asserted-by":"crossref","unstructured":"Park HK, Chung SJ (2013 May) New perspective on parkinsonism in frontotemporal lobar degeneration. J Mov Disord 6(1):1\u20138","DOI":"10.14802\/jmd.13001"},{"key":"1560_CR9","doi-asserted-by":"crossref","unstructured":"Foster NL, Wilhelmsen K, Sima AAF, Jones MZ, D\u2019Amato CJ, Gilman S et al (1997) Frontotemporal dementia and parkinsonism linked to chromosome 17: A consensus conference. Ann Neurol. ;41(6):706\u201315","DOI":"10.1002\/ana.410410606"},{"issue":"3\u20134","key":"1560_CR10","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1159\/000113678","volume":"5","author":"O Hornykiewicz","year":"2008","unstructured":"Hornykiewicz O (2008) Basic research on dopamine in Parkinson\u2019s disease and the discovery of the nigrostriatal dopamine pathway: the view of an eyewitness. Neurodegener Dis 5(3\u20134):114\u2013117","journal-title":"Neurodegener Dis"},{"key":"1560_CR11","doi-asserted-by":"crossref","unstructured":"Dijkstra AA, Voorn P, Berendse HW, Groenewegen HJ, Bank NB, Rozemuller AJM et al (2014 Sep) Stage-dependent nigral neuronal loss in incidental Lewy body and Parkinson\u2019s disease. Mov Disord Off J Mov Disord Soc 29(10):1244\u20131251","DOI":"10.1002\/mds.25952"},{"key":"1560_CR12","doi-asserted-by":"crossref","unstructured":"Williams DR, Holton JL, Strand C, Pittman A, de Silva R, Lees AJ et al (2007 Jun) Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson\u2019s syndrome. Brain J Neurol 130(Pt 6):1566\u20131576","DOI":"10.1093\/brain\/awm104"},{"key":"1560_CR13","doi-asserted-by":"crossref","unstructured":"Perry DC, Brown JA, Possin KL, Datta S, Trujillo A, Radke A et al (2017) Clinicopathological correlations in behavioural variant frontotemporal dementia. Brain J Neurol. Dec 1;140(12):3329\u201345","DOI":"10.1093\/brain\/awx254"},{"key":"1560_CR14","unstructured":"Bank NB Netherlands Brain Bank | Home [Internet]. Netherlands Brain Bank. [cited 2022 Jun 23]. Available from: https:\/\/www.brainbank.nl\/"},{"key":"1560_CR15","doi-asserted-by":"crossref","unstructured":"Gibb WR, Lees AJ (1989 Feb) The significance of the Lewy body in the diagnosis of idiopathic Parkinson\u2019s disease. Neuropathol Appl Neurobiol 15(1):27\u201344","DOI":"10.1111\/j.1365-2990.1989.tb01147.x"},{"key":"1560_CR16","doi-asserted-by":"crossref","unstructured":"H\u00f6glinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE et al (2017 Jun) Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord Off J Mov Disord Soc 32(6):853\u2013864","DOI":"10.1002\/mds.26973"},{"key":"1560_CR17","doi-asserted-by":"crossref","unstructured":"Armstrong MJ, Litvan I, Lang AE, Bak TH, Bhatia KP, Borroni B et al (2013 Jan) Criteria for the diagnosis of corticobasal degeneration. Neurology 29(5):496\u2013503","DOI":"10.1212\/WNL.0b013e31827f0fd1"},{"key":"1560_CR18","doi-asserted-by":"crossref","unstructured":"Klioueva NM, Rademaker MC, Dexter DT, Al-Sarraj S, Seilhean D, Streichenberger N et al (1996) 2015 Jul;122(7):937\u201340","DOI":"10.1007\/s00702-014-1353-5"},{"key":"1560_CR19","doi-asserted-by":"crossref","unstructured":"World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.JAMA. 2013 Nov27;310(20):2191\u20134","DOI":"10.1001\/jama.2013.281053"},{"key":"1560_CR20","unstructured":"Bank NB Diagnostics [Internet]. Netherlands Brain Bank. [cited 2023 Feb 7]. Available from: https:\/\/www.brainbank.nl\/brain-tissue\/diagnostics\/"},{"key":"1560_CR21","doi-asserted-by":"crossref","unstructured":"Braak H, Del Tredici K, R\u00fcb U, de Vos RAI, Jansen Steur ENH, Braak E (2003 Apr) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24(2):197\u2013211","DOI":"10.1016\/S0197-4580(02)00065-9"},{"key":"1560_CR22","doi-asserted-by":"crossref","unstructured":"Thal DR, R\u00fcb U, Orantes M, Braak H Phases of A\u03b2-deposition in the human brain and its relevance for the development of AD.Neurology. 2002 Jun25;58(12):1791\u2013800","DOI":"10.1212\/WNL.58.12.1791"},{"key":"1560_CR23","doi-asserted-by":"crossref","unstructured":"Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K (2006 Oct) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol (Berl) 112(4):389\u2013404","DOI":"10.1007\/s00401-006-0127-z"},{"key":"1560_CR24","doi-asserted-by":"crossref","unstructured":"Lee EB, Porta S, Michael Baer G, Xu Y, Suh E, Kwong LK et al (2017 Jul) Expansion of the classification of FTLD-TDP: distinct pathology associated with rapidly progressive frontotemporal degeneration. Acta Neuropathol (Berl) 134(1):65\u201378","DOI":"10.1007\/s00401-017-1679-9"},{"key":"1560_CR25","doi-asserted-by":"crossref","unstructured":"Bankhead P, Loughrey MB, Fern\u00e1ndez JA, Dombrowski Y, McArt DG, Dunne PD et al (2017 Dec) QuPath: open source software for digital pathology image analysis. Sci Rep 4:7:16878","DOI":"10.1038\/s41598-017-17204-5"},{"key":"1560_CR26","doi-asserted-by":"publisher","first-page":"627656","DOI":"10.3389\/fnana.2021.627656","volume":"15","author":"V Coulombe","year":"2021","unstructured":"Coulombe V, Saikali S, Goetz L, Takech MA, Philippe \u00c9, Parent A et al (2021) A Topographic Atlas of the human brainstem in the Ponto-Mesencephalic Junction Plane. Front Neuroanat 15:627656","journal-title":"Front Neuroanat"},{"key":"1560_CR27","doi-asserted-by":"crossref","unstructured":"Scarioni M, Gami-Patel P, Peeters CFW, de Koning F, Seelaar H, Mol MO et al (2022) Psychiatric symptoms of frontotemporal dementia and subcortical (co-)pathology burden: new insights.Brain J Neurol. Feb 8;awac043.","DOI":"10.1093\/brain\/awac043"},{"key":"1560_CR28","doi-asserted-by":"crossref","unstructured":"Jensen EC (2007) 2013 Mar;296(3):378\u201381","DOI":"10.1002\/ar.22641"},{"key":"1560_CR29","doi-asserted-by":"crossref","unstructured":"Knopman DS, Boeve BF, Parisi JE, Dickson DW, Smith GE, Ivnik RJ et al (2005 Apr) Antemortem diagnosis of frontotemporal lobar degeneration. Ann Neurol 57(4):480\u2013488","DOI":"10.1002\/ana.20425"},{"key":"1560_CR30","doi-asserted-by":"crossref","unstructured":"Josephs KA, Stroh A, Dugger B, Dickson DW (2009) Evaluation of subcortical pathology and clinical correlations in FTLD-U subtypes. Acta Neuropathol (Berl). Sep 1;118(3):349\u201358","DOI":"10.1007\/s00401-009-0547-7"},{"key":"1560_CR31","doi-asserted-by":"crossref","unstructured":"Mackenzie IR, Neumann M, Subcortical (2020 Jan) TDP-43 pathology patterns validate cortical FTLD-TDP subtypes and demonstrate unique aspects of C9orf72 mutation cases. Acta Neuropathol (Berl) 139(1):83\u201398","DOI":"10.1007\/s00401-019-02070-4"},{"key":"1560_CR32","doi-asserted-by":"crossref","unstructured":"Tan RH, Kril JJ, Fatima M, McGeachie A, McCann H, Shepherd C et al (2015 Oct) TDP-43 proteinopathies: pathological identification of brain regions differentiating clinical phenotypes. Brain J Neurol 138(Pt 10):3110\u20133122","DOI":"10.1093\/brain\/awv220"},{"key":"1560_CR33","doi-asserted-by":"crossref","unstructured":"Liu Y, Stern Y, Chun MR, Jacobs DM, Yau P, Goldman JE (1997 Mar) Pathological correlates of extrapyramidal signs in Alzheimer\u2019s disease. Ann Neurol 41(3):368\u2013374","DOI":"10.1002\/ana.410410312"},{"key":"1560_CR34","doi-asserted-by":"crossref","unstructured":"Schneider JA, Li J, Li Y, Wilson RS, Kordower JH, Bennett DA (2006 Jan) Substantia nigra tangles are related to gait impairment in older persons. Ann Neurol 59(1):166\u2013173","DOI":"10.1002\/ana.20723"},{"key":"1560_CR35","doi-asserted-by":"crossref","unstructured":"Park HK, Park KH, Yoon B, Lee JH, Choi SH, Joung JH et al Clinical characteristics of parkinsonism in frontotemporal dementia according to subtypes.J Neurol Sci. 2017 Jan15;372:51\u20136","DOI":"10.1016\/j.jns.2016.11.033"},{"issue":"4","key":"1560_CR36","doi-asserted-by":"publisher","first-page":"e0153852","DOI":"10.1371\/journal.pone.0153852","volume":"11","author":"C Gasca-Salas","year":"2016","unstructured":"Gasca-Salas C, Masellis M, Khoo E, Shah BB, Fisman D, Lang AE et al (2016) Characterization of Movement Disorder Phenomenology in genetically proven, familial Frontotemporal Lobar Degeneration: a systematic review and Meta-analysis. PLoS ONE 11(4):e0153852","journal-title":"PLoS ONE"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-023-01560-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-023-01560-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-023-01560-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,10]],"date-time":"2023-12-10T15:41:09Z","timestamp":1702222869000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-023-01560-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,12]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1560"],"URL":"https:\/\/doi.org\/10.1186\/s40478-023-01560-7","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,12]]},"assertion":[{"value":"9 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Post-mortem brain tissue was obtained from the Netherlands Brain Bank. All donors had provided informed consent for autopsy and the use of medical records for research purposes. This document summarizes the ethical principles abided by the Netherlands Brain Bank (NBB) and describes legal embedding of the procedures of the NBB ().","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"63"}}